GlassScriptPhysician profile
Louis M Varner
NPI 1669682134
$9,862.27
in general payments reported to CMS, 2019-2025
72 companies · $2,416 in 2025
The $2,416 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,554 · 2020: $419 · 2021: $630 · 2022: $1,363 · 2023: $1,557 · 2024: $1,923 · 2025: $2,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,895.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $762.59 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Merck Sharp & Dohme LLC | $617.60 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $501.78 | 2019-2025 | |
| Incyte Corporation | $451.81 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Daiichi Sankyo INC. | $443.66 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Astrazeneca Pharmaceuticals LP | $373.45 | 2019-2025 | Enhertu |
| Celgene Corporation | $337.55 | 2019-2025 | Reblozyl, Opdualag |
| Pfizer INC. | $309.63 | 2019-2025 | |
| Lilly USA, LLC | $298.14 | 2019-2025 | Jaypirca, Verzenio |
| Genentech USA, INC. | $292.33 | 2019-2025 | Polivy, Venclexta, Phesgo |
| Seagen INC. | $266.75 | 2019-2023 | Adcetris |
| Astellas Pharma US INC | $263.41 | 2021-2025 | Xtandi, Vyloy, Xospata |
| Genzyme Corporation | $256.29 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $240.64 | 2019-2024 | Opdivo |
| Bayer Healthcare Pharmaceuticals INC. | $203.02 | 2019-2025 |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $197.63 | 2023-2025 | Epkinly, Tivdak |
| Exelixis INC. | $187.59 | 2019-2025 | Cabometyx |
| Eisai INC. | $176.32 | 2019-2025 | |
| Amgen INC. | $175.02 | 2019-2023 | Kyprolis, Blincyto |
| Abbvie INC. | $168.65 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $168.30 | 2021-2025 | Libtayo |
| Kite Pharma, INC. | $159.23 | 2019-2025 | Yescarta |
| Puma Biotechnology, INC. | $147.43 | 2019-2025 | |
| Gilead Sciences, INC. | $140.27 | 2019-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $134.03 | 2021-2025 | Zejula, Jemperli, Ojjaara |
| Pharmacyclics LLC, An Abbvie Company | $127.20 | 2021-2023 | Imbruvica |
| Janssen Pharmaceuticals, INC | $126.23 | 2019-2024 | Xarelto |
| Beigene USA, INC. | $122.62 | 2021-2023 | Brukinsa |
| Emd Serono, INC. | $122.34 | 2023-2025 | Bavencio |
| Jazz Pharmaceuticals INC. | $116.48 | 2022-2025 | |
| Stemline Therapeutics INC. | $109.23 | 2023-2025 | Orserdu |
| Adc Therapeutics America, INC. | $103.22 | 2022-2024 | |
| Tersera Therapeutics LLC | $101.77 | 2023-2025 | Zoladex, Xermelo |
| Pharmacosmos Therapeutics INC. | $96.43 | 2021-2025 | Monoferric, Cosela |
| Deciphera Pharmaceuticals INC. | $88.74 | 2023-2025 | Qinlock, Tgct |
| Octapharma USA, INC. | $88.68 | 2024-2025 | Octagam Immune Globulin (Human), Panzyga |
| Alexion Pharmaceuticals, INC. | $80.02 | 2019-2025 | Ultomiris |
| Ipsen Biopharmaceuticals, INC | $77.24 | 2019-2024 | Onivyde, Somatuline Depot |
| Rigel Pharmaceuticals, INC. | $77.08 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Takeda Pharmaceuticals U.S.A., INC. | $75.18 | 2019-2025 | Iclusig, Ninlaro |
| Beone Medicines USA, INC. | $67.68 | 2025 | Brukinsa, Tevimbra |
| Spectrum Pharmaceuticals INC. | $65.31 | 2024-2025 | Rolvedon |
| Sobi, INC | $64.96 | 2022-2025 | |
| G1 Therapeutics, INC. | $63.59 | 2022-2023 | Cosela |
| Fresenius Kabi USA, LLC | $62.02 | 2025 | Stimufend |
| Aveo Pharmaceuticals, INC. | $57.71 | 2025 | |
| Verastem, INC. | $56.92 | 2019-2020 | |
| Springworks Therapeutics, INC. | $52.52 | 2024-2025 | Ogsiveo |
| Tesaro, INC. | $49.28 | 2019 | |
| Pharmaessentia USA Corporation | $45.41 | 2024-2025 | Besremi |
| Karyopharm Therapeutics INC. | $44.53 | 2023-2025 | Xpovio |
| Foundation Medicine, INC. | $34.81 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.69 | 2019 | |
| Blueprint Medicines Corporation | $32.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $32.76 | 2019 | |
| Morphosys, US INC. | $27.42 | 2021 | |
| Legend Biotech USA INC. | $24.90 | 2025 | Carvykti |
| Adaptive Biotechnologies Corporation | $22.70 | 2024 | Clonoseq |
| Progenics Pharmaceuticals, INC. | $22.00 | 2022 | |
| Taiho Oncology, INC. | $21.46 | 2024 | |
| Cti Biopharma Corp. | $20.93 | 2022 | |
| Janssen Scientific Affairs, LLC | $18.89 | 2024 | Tecvayli, Darzalex, Talvey |
| Shield Therapeutics INC | $16.83 | 2024 | |
| Mirati Therapeutics, INC. | $16.49 | 2023 | Krazati |
| Grifols USA, LLC | $16.30 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.77 | 2024 | Sancuso |
| Novocure INC. | $15.73 | 2025 | Optune Lua (Novottf-200t) |
| Myriad Genetic Laboratories, INC. | $15.67 | 2024 | Precisetumor |
| Teva Pharmaceuticals USA, INC. | $15.18 | 2024 | Truxima |
| Nestle Healthcare Nutrition INC. | $14.89 | 2021 | |
| Secura Bio, INC. | $13.31 | 2022 | |
| Array Biopharma INC | $13.08 | 2020 |
Drugs and devices associated with these payments
Keytruda $390Enhertu $280Reblozyl $268Epkinly $219Imbruvica $179Lynparza $158Darzalex $156Libtayo $144Pluvicto $144Xtandi $143Cabometyx $142Tecvayli $140Padcev $140Jakafi $137Sarclisa $111Polivy $110Orserdu $109Welireg $109Monjuvi $102Rybrevant $98.45Jaypirca $95.76Verzenio $93.77Brukinsa $91.97Kisqali $90.73Qinlock $88.74Carvykti $85.90Elrexfio $85.35Adcetris $82.70Cosela $79.56Zoladex $76.98Scemblix $75.17Venclexta $74.30Zepzelca $73.38Nubeqa $69.35Xarelto $68.36Rolvedon $65.31Octagam Immune Globulin (Human) $63.96Ultomiris $63.87Jemperli $63.86Zejula $63.86Bosulif $63.80Lutathera $63.61Inlyta $60.16Fotivda $57.71Lenvima $55.61Talvey $54.46Erleada $53.70Ogsiveo $52.52Vitrakvi $50.83Stivarga $50.83Injectafer $49.56Tgct $46.94Besremi $45.41Trodelvy $44.67Xpovio $44.53Vyloy $43.69Monoferric $40.52Xospata $38.51Tasigna $38.42Stimufend $37.22Tivdak $36.06Yescarta $35.67Orgovyx $35.37Talzenna $35.37Balversa $33.98Iclusig $33.90Xofigo $33.89Opdivo $33.63Tavalisse $33.46Jevtana $33.46Rezlidhia $33.46Nerlynx $33.01Kyprolis $30.13Vonjo $29.65Datroway $28.89Bavencio $28.50Mekinist $27.11Xermelo $24.79Panzyga $24.72Ziihera $24.69Niktimvo $23.47Clonoseq $22.70Tevimbra $22.25Besponsa $22.14Inqovi $21.46Lonsurf $21.46Ninlaro $19.06Gavreto $18.66Ojjaara $18.11Phesgo $17.77Tecentriq $17.66Onivyde $17.11Somatuline Depot $17.11Accrufer $16.83Krazati $16.49Sancuso $15.77Optune Lua (Novottf-200t) $15.73Precisetumor $15.67Akeega $15.20Truxima $15.18
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Varner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.